0001140361-15-045397.txt : 20151222 0001140361-15-045397.hdr.sgml : 20151222 20151222180035 ACCESSION NUMBER: 0001140361-15-045397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150709 FILED AS OF DATE: 20151222 DATE AS OF CHANGE: 20151222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murray Mark J. CENTRAL INDEX KEY: 0001628383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 151303836 MAIL ADDRESS: STREET 1: C/O TEKMIRA PHARMACEUTICALS CORP STREET 2: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 4 1 doc1.xml FORM 4 X0306 4 2015-07-09 0 0001447028 Arbutus Biopharma Corp ABUS 0001628383 Murray Mark J. C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 0 1 0 0 President & CEO Employee Stock Option (right to buy) 17.57 2015-07-09 4 A 0 100000 0 A 2025-03-30 Common Shares 100000 100000 D The option vests as follows: 1/3 on 3/30/2016; 1/3/ on 3/30/2017; and 1/3 on 3/30/2018. /s/ Mark J. Murray 2015-12-22